Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
PHASE4
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, w...
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
PHASE3
Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affec...
Status
Active Not Recruiting
Location
Duplicate_Providence Medical Foundation /ID# 222633
Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms
PHASE1
This phase I trial studies the side effects and best dose of pacritinib whe...